MGLL and neoplasm: Here, the authors found partial reversal of tumour growth defects observed with MAGL shRNA-transfected PC3 cells by treatment of mice with a high-fat diet or a CB1 receptor antagonist, and fully reversal by pre-treatment with both regimes.